Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer
  2. Floudas, Charalampos S; Goswami, Meghali; Donahue, Renee N; Strauss, Julius; Pastor, Danielle M; Redman, Jason M; Brownell, Isaac; Turkbey, Evrim B; Steinberg, Seth M; Cordes, Lisa M; Marté, Jennifer L; Khan, Maheen H; McMahon, Sheri; Lamping, Elizabeth; Manu,Michell; Manukyan,Manuk; Brough, Douglas E; Lankford, Amy; Jochems, Caroline; Schlom, Jeffrey; Gulley, James L
  3. Cancer Immunology, Immunotherapy : CII. 2025, Mar 21; 74(5): 155.
  1. 2.   Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization
  2. Becker, William; Olkhanud, Purevdorj B; Seishima, Noriko; Moreno, Paloma A; Goldfarbmuren,Kate; Maeng, Hoyoung M; Berzofsky, Jay A
  3. Journal for Immunotherapy of Cancer. 2024, Jul 01; 12(7):
  1. 3.   Recent Advances in the Development of Non-Invasive Imaging Probes for Cancer Immunotherapy
  2. Kazim,Muhammad; Yoo,Euna
  3. Angewandte Chemie (International ed. in English). 2023, Oct 16; e202310694.
  1. 4.   First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Ra, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
  2. Leidner, Rom; Conlon, Kevin; McNeel, Douglas G; Wang-Gillam, Andrea; Gupta, Sumati; Wesolowski, Robert; Chaudhari, Monica; Hassounah, Nadia; Lee, Jong Bong; Ho Lee, Lang; O'Keeffe, Jessica A; Lewis, Nancy; Pavlakis,George; Thompson, John A
  3. Journal for Immunotherapy of Cancer. 2023, Oct; 11(10):
  1. 5.   CD47-Dependent Regulation of Immune Checkpoint Gene Expression and MYCN mRNA Splicing in Murine CD8 and Jurkat T Cells
  2. Kaur, Sukhbir; Awad, Duha; Finney, Richard P; Meyer, Thomas J; Singh, Satya P; Cam, Margaret C; Karim,Baktiar; Warner,Andrew; Roberts, David D
  3. International Journal of Molecular Sciences. 2023, Jan 30; 24(3):
  1. 6.   Multiparameter immunohistochemistry analysis of HIV DNA, RNA and immune checkpoints in lymph node tissue
  2. Richardson, Zuwena A; Deleage,Claire; Tutuka, Candani S A; Walkiewicz, Marzena; Del Río-Estrada, Perla M; Pascoe, Rachel D; Evans, Vanessa A; Reyesteran, Gustavo; Gonzales, Michael; Roberts-Thomson, Samuel; González-Navarro, Mauricio; Torres-Ruiz, Fernanda; Estes, Jacob D; Lewin, Sharon R; Cameron, Paul U
  3. Journal of Immunological Methods. 2021, Dec 01; 113198.
  1. 7.   Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
  2. Krug, Karsten; Jaehnig, Eric J; Satpathy, Shankha; Blumenberg, Lili; Karpova, Alla; Anurag, Meenakshi; Miles, George; Mertins, Philipp; Geffen, Yifat; Tang, Lauren C; Heiman, David I; Cao, Song; Maruvka, Yosef E; Lei, Jonathan T; Huang, Chen; Kothadia, Ramani B; Colaprico, Antonio; Birger, Chet; Wang, Jarey; Dou, Yongchao; Wen, Bo; Shi, Zhiao; Liao, Yuxing; Wiznerowicz, Maciej; Wyczalkowski, Matthew A; Chen, Xi Steven; Kennedy, Jacob J; Paulovich, Amanda G; Thiagarajan,Mathangi; Kinsinger, Christopher R; Hiltke, Tara; Boja, Emily S; Mesri, Mehdi; Robles, Ana I; Rodriguez, Henry; Westbrook, Thomas F; Ding, Li; Getz, Gad; Clauser, Karl R; Fenyö, David; Ruggles, Kelly V; Zhang, Bing; Mani, D R; Carr, Steven A; Ellis, Matthew J; Gillette, Michael A
  3. Cell. 2020, NOV 25; 183(5): 1436-+.
  1. 8.   Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project
  2. Merino, Diana M; McShane, Lisa M; Fabrizio, David; Funari, Vincent; Chen, Shu-Jen; White, James R; Wenz, Paul; Baden, Jonathan; Barrett, J Carl; Chaudhary, Ruchi; Chen,Li; Chen, Wangjuh Sting; Cheng, Jen-Hao; Cyanam, Dinesh; Dickey, Jennifer S; Gupta, Vikas; Hellmann, Matthew; Helman, Elena; Li, Yali; Maas, Joerg; Papin, Arnaud; Patidar,Rajesh; Quinn, Katie J; Rizvi, Naiyer; Tae, Hongseok; Ward, Christine; Xie, Mingchao; Zehir, Ahmet; Zhao, Chen; Dietel, Manfred; Stenzinger, Albrecht; Stewart, Mark; Allen, Jeff
  3. Journal for immunotherapy of cancer. 2020, Mar; 8(1): pii: e000147..
  1. 9.   Durvalumab in Combination with Olaparib in Patients with Relapsed Small Cell Lung Cancer: Results from a Phase II Study
  2. Thomas, Anish; Vilimas, Rasa; Trindade, Christopher; Erwin-Cohen,Rebecca; Roper, Nitin; Xi, Liqiang; Krishnasamy, Venkatesh; Levy, Elliot; Mammen, Andy; Nichols, Samantha; Chen, Yuanbin; Velcheti, Vamsidhar; Yin, Faye; Szabo, Eva; Pommier, Yves; Steinberg, Seth M; Trepel, Jane B; Raffeld, Mark; Young,Howard; Khan, Javed; Hewitt, Stephen; Lee, Jung-Min
  3. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2019, AUG; 14(8): 1447-1457.
  1. 10.   A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses
  2. Zimmer, Alexandra S; Nichols,Erin; Cimino-Mathews, Ashley; Peer, Cody; Cao, Liang; Lee, Min-Jung; Kohn, Elise C; Annunziata, Christina M; Lipkowitz, Stanley; Trepel, Jane B; Sharma, Rajni; Mikkilineni, Lekha; Gatti-Mays, Margaret; Figg, William D; Houston, Nicole D; Lee, Jung-Min
  3. Journal for immunotherapy of cancer. 2019, Jul 25; 7(1): 197.
  1. 11.   Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases
  2. Ranjan, Surabhi; Quezado, Martha; Garren, Nancy; Boris, Lisa; Siegel, Christine; Lopes Abath Neto, Osorio; Theeler, Brett J; Park, Deric M; Nduom, Edjah; Zaghloul, Kareem A; Gilbert, Mark R; Wu, Jing
  3. BMC Cancer. 2018, Mar 01; 18(1): 239.
  1. 12.   Measuring Tumor Mutational Burden Using Whole-Exome Sequencing
  2. Vilimas,Tomas
  3. Methods in molecular biology (Clifton, N.J.). 2020 2055: 63-91.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel